Braeburn has one mission: to fight the opioid overdose crisis. The work we are doing can make a difference in the lives of patients who often shoulder the burden of treatment themselves. We aim to reduce stigma by raising awareness that opioid use disorder (OUD) is a chronic brain disease best treated by evidence-based medication for addiction treatment. Together with counseling and support, Braeburn’s next generation medicines aim to support patients focusing on the reintegration of their lives with their families and communities.
Braeburn aims to provide the healthcare professional (HCP) with a flexible and customizable platform of medications for opioid use disorder that are HCP-administered and, for this reason, are expected to be less prone to abuse and diversion. HCP-administered medications are given directly by the healthcare professional to their patient and are never in the patients’ hands. Therefore, greater adherence during the prescribed dosage period may be possible.
These are unwavering and will pass the test of time.
These define how we work together to achieve our goals: